EP Patent

EP3798224B1 — Solid state forms of ixazomib citrate

Assigned to Assia Chemical Industries Ltd · Expires 2025-03-19 · 1y expired

What this patent protects

Patent listed against ixazomib-citrate.

Drugs covered by this patent

ixazomib-citrate (IXAZOMIB CITRATE)

Patent Metadata

Patent number: EP3798224B1
Jurisdiction: EP
Classification: —
Expires: 2025-03-19
Drug substance claim: No
Drug product claim: No
Assignee: Assia Chemical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.